Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study

Pancreatic cancer still has one of the worst prognoses of all solid malignancies, despite developments in cancer knowledge and care. Research into pancreatic cancer has not fully translated into clinical improvements and as a result, fewer than 1% of patients survive 10 years post-diagnosis. This bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichols, Lucy, Lawrence, Rachel, Haboubi, Hasan, Al-Sarireh, Bilal, Doak, Shareen, Jenkins, Gareth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Manuscripts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181792/
https://www.ncbi.nlm.nih.gov/pubmed/37006185
http://dx.doi.org/10.1093/mutage/gead006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181792/
https://www.ncbi.nlm.nih.gov/pubmed/37006185
http://dx.doi.org/10.1093/mutage/gead006

Ejemplares similares